Management of patients with abnormal uterine bleeding after hysteroscopy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023083

Enrollment

Unknown

Registered

2019-05-10

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal uterine bleeding

Interventions

Experimental group:The APP regularly sends alert messages combined with telephone follow-up, the follow-up time is 1 week, 1 month, 3 months, 6 months and 12 months after discharge

Control group:A telephone follow-up is conducted after discharge

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: From June 2019 to March 2021, the patients are hospitalized in our department, and are diagnosed as abnormal uterine bleeding after cureting by hysteroscopy.

Exclusion criteria

Exclusion criteria: Pregnancy and puerperal hemorrhage, postmenopausal hemorrhage, preadolescent hemorrhage, abnormal uterine hemorrhage without hysteroscopy and curettage are excluded.

Design outcomes

Primary

Measure	Time frame
Improvement in the quality of life;Uterine resection rate;Satisfaction;	—

Countries

China

Contacts

Public ContactJiang Yuxia

The People’s Hospital of Shapingba District

429578978@qq.com+86 13677667004

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026